Skip to main content

Table 5 Step counts for at home monitoring periods of 14+/−3 days W/O Keeogo and W Keeogo, randomized in sequence by group A (W-W/O) and B (W/O-W). Results for ITT analysis (N = 29) and PP analysis (N = 24)

From: Evaluation of the Keeogo exoskeleton for assisting ambulatory activities in people with multiple sclerosis: an open-label, randomized, cross-over trial

Steps/day at home (ITT)

Total

A

B

Mean

SD

Mean

SD

Mean

SD

 hWO

4425.1

2897.0

4523.9

3854.6

4326.3

1597.5

 hW

4693.5

2996.0

4599.2

3811.0

4787.9

2024.9

 δ

268.4

739.4

75.2

404.3

461.6

944.3

Steps/day at home (PP)

Mean

SD

Mean

SD

Mean

SD

 hWO

4636.9

3096.4

4984.7

4220.5

4318.0

1658.3

 hW

4963.6

3184.2

5080.4

4156.7

4856.5

2131.7

 δ

326.8

806.9

95.8

458.6

538.5

1004.4

  1. ITT Intention to treat analysis, PP Per-protocol analysis
  2. hW Home PAL with Keeogo, hWO Home PAL without Keeogo, δ hW-hWO